Jenoptik (ETR:JEN) received a €34.50 ($40.12) target price from analysts at Hauck & Aufhaeuser in a note issued to investors on Friday. The firm currently has a “neutral” rating on the stock. Hauck & Aufhaeuser’s price target suggests a potential upside of 4.86% from the stock’s current price.
A number of other research firms have also issued reports on JEN. Warburg Research set a €33.50 ($38.95) target price on shares of Jenoptik and gave the company a “neutral” rating in a report on Thursday. Kepler Capital Markets set a €34.50 ($40.12) target price on shares of Jenoptik and gave the company a “neutral” rating in a report on Thursday. Baader Bank set a €30.00 ($34.88) target price on shares of Jenoptik and gave the company a “neutral” rating in a report on Thursday. DZ Bank restated a “neutral” rating on shares of Jenoptik in a report on Thursday. Finally, HSBC set a €30.00 ($34.88) target price on shares of Jenoptik and gave the company a “neutral” rating in a report on Thursday, February 14th. One investment analyst has rated the stock with a sell rating and seven have given a hold rating to the stock. The company currently has an average rating of “Hold” and an average target price of €31.21 ($36.30).
ETR:JEN opened at €32.90 ($38.26) on Friday. The stock has a market capitalization of $1.88 billion and a price-to-earnings ratio of 22.88. The company has a debt-to-equity ratio of 23.51, a quick ratio of 1.22 and a current ratio of 2.18. Jenoptik has a 12-month low of €22.02 ($25.60) and a 12-month high of €39.54 ($45.98).
Jenoptik Company Profile
Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.
Featured Story: Is a Roth IRA right for you?
Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.